| Literature DB >> 22017873 |
Inna S Afonina1, Graham A Tynan, Susan E Logue, Sean P Cullen, Michael Bots, Alexander U Lüthi, Emer P Reeves, Noel G McElvaney, Jan P Medema, Ed C Lavelle, Seamus J Martin.
Abstract
Granzyme B is a cytotoxic lymphocyte-derived protease that plays a central role in promoting apoptosis of virus-infected target cells, through direct proteolysis and activation of constituents of the cell death machinery. However, previous studies have also implicated granzymes A and B in the production of proinflammatory cytokines, via a mechanism that remains undefined. Here we show that IL-1α is a substrate for granzyme B and that proteolysis potently enhanced the biological activity of this cytokine in vitro as well as in vivo. Consistent with this, compared with full-length IL-1α, granzyme B-processed IL-1α exhibited more potent activity as an immunoadjuvant in vivo. Furthermore, proteolysis of IL-1α within the same region, by proteases such as calpain and elastase, was also found to enhance its biological potency. Thus, IL-1α processing by multiple immune-related proteases, including granzyme B, acts as a switch to enhance the proinflammatory properties of this cytokine.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22017873 PMCID: PMC3319689 DOI: 10.1016/j.molcel.2011.07.037
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970